Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Neuhaus

Showing results (51-60 of 83) with videos related to

Pageof 9
Sort By:
Transplantation|August 13, 1998
Pretransplant virological markers hepatitis C virus genotype and viremia level are not helpful in predicting individual outcome after orthotopic liver transplantationT Berg, U Hopf, W O Bechstein, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 26, 2000
Lamivudine as first- and second-line treatment of hepatitis B infection after liver transplantationD Seehofer, N Rayes, T Berg, et al.
Transplantation|June 3, 2000
Additional interferon alpha for lamivudine resistant hepatitis B infection after liver transplantation: a preliminary reportD Seehofer, N Rayes, T Berg, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|August 22, 2009
Immunization of liver and renal transplant recipients: a seroepidemiological and sociodemographic surveyC Chesi, M Günther, D Huzly, et al.
Transplantation Proceedings|March 17, 2007
Immediate recovery of renal function after orthotopic liver transplantation in a patient with hepatorenal syndrome requiring hemodialysis for more than 8 monthsC Storm, W M Bernhardt, E Schaeffner, et al.
Zeitschrift Fur Gastroenterologie|September 7, 2002
Combination prophylaxis with Hepatitis B immunoglobulin and lamivudine after liver transplantation minimizes HBV recurrence rates unless evolution of pretransplant lamivudine resistanceD Seehofer, N Rayes, T Steinmüller, et al.
Clinical Transplantation|February 1, 1997
Cardiovascular risk factors in long-term follow-up after orthotopic liver transplantationO Guckelberger, W O Bechstein, R Neuhaus, et al.
Transplantation|October 27, 1997
Treatment of cyclosporine-related adverse effects by conversion to tacrolimus after liver transplantationJ Pratschke, R Neuhaus, S G Tullius, et al.
Cancer|September 26, 1997
De novo malignancies after liver transplantation using tacrolimus-based protocols or cyclosporine-based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulinS Jonas, N Rayes, U Neumann, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|May 1, 1997
[Contrast agent enhanced duplex ultrasonography: visualization of the hepatic artery after orthotopic liver transplantation]M Gutberlet, S Venz, R Neuhaus, et al.
Pageof 9

Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
Transplantation|August 13, 1998
Pretransplant virological markers hepatitis C virus genotype and viremia level are not helpful in predicting individual outcome after orthotopic liver transplantationT Berg, U Hopf, W O Bechstein, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 26, 2000
Lamivudine as first- and second-line treatment of hepatitis B infection after liver transplantationD Seehofer, N Rayes, T Berg, et al.
Transplantation|June 3, 2000
Additional interferon alpha for lamivudine resistant hepatitis B infection after liver transplantation: a preliminary reportD Seehofer, N Rayes, T Berg, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|August 22, 2009
Immunization of liver and renal transplant recipients: a seroepidemiological and sociodemographic surveyC Chesi, M Günther, D Huzly, et al.
Transplantation Proceedings|March 17, 2007
Immediate recovery of renal function after orthotopic liver transplantation in a patient with hepatorenal syndrome requiring hemodialysis for more than 8 monthsC Storm, W M Bernhardt, E Schaeffner, et al.
Zeitschrift Fur Gastroenterologie|September 7, 2002
Combination prophylaxis with Hepatitis B immunoglobulin and lamivudine after liver transplantation minimizes HBV recurrence rates unless evolution of pretransplant lamivudine resistanceD Seehofer, N Rayes, T Steinmüller, et al.
Clinical Transplantation|February 1, 1997
Cardiovascular risk factors in long-term follow-up after orthotopic liver transplantationO Guckelberger, W O Bechstein, R Neuhaus, et al.
Transplantation|October 27, 1997
Treatment of cyclosporine-related adverse effects by conversion to tacrolimus after liver transplantationJ Pratschke, R Neuhaus, S G Tullius, et al.
Cancer|September 26, 1997
De novo malignancies after liver transplantation using tacrolimus-based protocols or cyclosporine-based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulinS Jonas, N Rayes, U Neumann, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|May 1, 1997
[Contrast agent enhanced duplex ultrasonography: visualization of the hepatic artery after orthotopic liver transplantation]M Gutberlet, S Venz, R Neuhaus, et al.
Pageof 9